Mathers Edward T. - 05 Feb 2026 Form 3 Insider Report for SpyGlass Pharma, Inc. (SGP)

Role: 10%+ Owner
Signature: /s/ Zachary Bambach, attorney-in-fact
Issuer symbol: SGP
Transactions as of: 05 Feb 2026
Net transactions value: $0
Form type: 3
Filing time: 05 Feb 2026, 16:05:05 UTC
Previous filing: 02 Jan 2026
Next filing: 11 Feb 2026
SEC: View on sec.gov

Quoteable Key Fact

"Mathers Edward T. filed Form 3 for SpyGlass Pharma, Inc. (SGP) on 05 Feb 2026."

Quick Takeaways

This page summarizes Mathers Edward T.'s Form 3 filing for SpyGlass Pharma, Inc. (SGP).
0 reported transactions and 4 derivative rows are listed below.
Filing timestamp: 05 Feb 2026, 16:05.

What Changed

Previous filing in this sequence was filed on 02 Jan 2026.
Current net transaction value: $0.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC Source

Ownership activity is grounded in SEC Form 3 disclosures.

See Original Filing

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mathers Edward T	10%+ Owner	104 5TH AVENUE, 19TH FLOOR, NEW YORK	/s/ Zachary Bambach, attorney-in-fact	05 Feb 2026	0001328625

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Date	Underlying Class	Amount	Ownership	Footnotes
holding	SGP	Series B Preferred Stock	05 Feb 2026	Common Stock	1,619,240	See Note 2	F1, F2
holding	SGP	Series C-1 Preferred Stock	05 Feb 2026	Common Stock	1,370,168	See Note 2	F1, F2
holding	SGP	Series C-2 Preferred Stock	05 Feb 2026	Common Stock	1,370,168	See Note 2	F1, F2
holding	SGP	Series D Preferred Stock	05 Feb 2026	Common Stock	737,962	See Note 2	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All shares of the preferred stock, par value $0.00001 per share, of the Issuer will automatically be converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock") prior to the closing of the Issuer's initial public offering of its Common Stock.
F2	The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest.

Content

All shares of the preferred stock, par value $0.00001 per share, of the Issuer will automatically be converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock") prior to the closing of the Issuer's initial public offering of its Common Stock.

The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest.